Swinburne Centre for Human Psychopharmacology PhD candidate, Greg Kennedy, has been recognised for his contribution to the advancement of Alzheimer’s Disease research.

To read the full story...SUBSCRIBE NOW

Existing Subscribers Login Below:

Log In